FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q38447818> ?p ?o ?g. }

• Q38447818 description "2004 nî lūn-bûn" @default.
• Q38447818 description "2004年の論文" @default.
• Q38447818 description "2004年論文" @default.
• Q38447818 description "2004年論文" @default.
• Q38447818 description "2004年論文" @default.
• Q38447818 description "2004年論文" @default.
• Q38447818 description "2004年論文" @default.
• Q38447818 description "2004年论文" @default.
• Q38447818 description "2004年论文" @default.
• Q38447818 description "2004年论文" @default.
• Q38447818 description "2004年论文" @default.
• Q38447818 description "2004年论文" @default.
• Q38447818 description "2004年论文" @default.
• Q38447818 description "2004년 논문" @default.
• Q38447818 description "article científic" @default.
• Q38447818 description "article scientific" @default.
• Q38447818 description "article scientifique" @default.
• Q38447818 description "articol științific" @default.
• Q38447818 description "articolo scientifico" @default.
• Q38447818 description "artigo científico" @default.
• Q38447818 description "artigo científico" @default.
• Q38447818 description "artigo científico" @default.
• Q38447818 description "artikel ilmiah" @default.
• Q38447818 description "artikull shkencor" @default.
• Q38447818 description "artikulong pang-agham" @default.
• Q38447818 description "artykuł naukowy" @default.
• Q38447818 description "artículo científico" @default.
• Q38447818 description "artículu científicu espublizáu en 2004" @default.
• Q38447818 description "bilimsel makale" @default.
• Q38447818 description "bài báo khoa học" @default.
• Q38447818 description "naučni članak" @default.
• Q38447818 description "scienca artikolo" @default.
• Q38447818 description "scientific article published on May 2004" @default.
• Q38447818 description "scientific article published on May 2004" @default.
• Q38447818 description "scientific article published on May 2004" @default.
• Q38447818 description "teaduslik artikkel" @default.
• Q38447818 description "tieteellinen artikkeli" @default.
• Q38447818 description "tudományos cikk" @default.
• Q38447818 description "vedecký článok" @default.
• Q38447818 description "vetenskaplig artikel" @default.
• Q38447818 description "videnskabelig artikel" @default.
• Q38447818 description "vitenskapelig artikkel" @default.
• Q38447818 description "vitskapeleg artikkel" @default.
• Q38447818 description "vědecký článek" @default.
• Q38447818 description "wetenschappelijk artikel" @default.
• Q38447818 description "wissenschaftlicher Artikel" @default.
• Q38447818 description "επιστημονικό άρθρο" @default.
• Q38447818 description "мақолаи илмӣ" @default.
• Q38447818 description "наукова стаття, опублікована в травні 2004" @default.
• Q38447818 description "научна статия" @default.
• Q38447818 description "научная статья" @default.
• Q38447818 description "научни чланак" @default.
• Q38447818 description "научни чланак" @default.
• Q38447818 description "מאמר מדעי" @default.
• Q38447818 description "مقالة علمية نشرت في مايو 2004" @default.
• Q38447818 description "বৈজ্ঞানিক নিবন্ধ" @default.
• Q38447818 description "บทความทางวิทยาศาสตร์" @default.
• Q38447818 description "სამეცნიერო სტატია" @default.
• Q38447818 name "Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial" @default.
• Q38447818 name "Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial" @default.
• Q38447818 name "Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial" @default.
• Q38447818 type Item @default.
• Q38447818 label "Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial" @default.
• Q38447818 label "Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial" @default.
• Q38447818 label "Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial" @default.
• Q38447818 prefLabel "Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial" @default.
• Q38447818 prefLabel "Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial" @default.
• Q38447818 prefLabel "Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial" @default.
• Q38447818 P1433 Q38447818-B4AEE95D-F128-4B7C-9793-80BF1C566078 @default.
• Q38447818 P1476 Q38447818-52819108-80E1-4A23-A396-83063F2E49DF @default.
• Q38447818 P2093 Q38447818-16E5662E-E2C2-492E-8D64-C37E1B3DF730 @default.
• Q38447818 P2093 Q38447818-40FDB46A-8149-4D21-883F-91F6E26CEADC @default.
• Q38447818 P2093 Q38447818-67A6D8E0-A374-4672-94A2-05CA3B7B028F @default.
• Q38447818 P2093 Q38447818-71245E15-9312-4021-8562-531A63DD3D35 @default.
• Q38447818 P2093 Q38447818-83DE95AF-A22B-436C-812D-9AD0A9ADDCD0 @default.
• Q38447818 P2093 Q38447818-C61B6F43-9C36-4EA5-BAF8-032FB5CE3C34 @default.
• Q38447818 P2093 Q38447818-EFC7B452-8C1D-4003-934C-015739B180BB @default.
• Q38447818 P2093 Q38447818-F10D6899-E862-4E6B-9DC6-044E706CDD88 @default.
• Q38447818 P2093 Q38447818-FFCD5CAF-0AC9-45D9-8357-30CB2520E921 @default.
• Q38447818 P2860 Q38447818-06193A51-0BE3-4C2C-AA33-82E17B814DE6 @default.
• Q38447818 P2860 Q38447818-086AC551-D454-4266-B947-8F7DE80F139C @default.
• Q38447818 P2860 Q38447818-153F9068-3DD9-4F2F-84B6-D57928A479C6 @default.
• Q38447818 P2860 Q38447818-301AD00D-D119-4FCB-92A5-71C4B77CCCD0 @default.
• Q38447818 P2860 Q38447818-3EB28782-35E8-468F-9B55-DE31ED1733D4 @default.
• Q38447818 P2860 Q38447818-40377688-BCE2-4FBB-86ED-1CDD8866C8D7 @default.
• Q38447818 P2860 Q38447818-478A6051-C466-4C36-AF02-6E6366CFF36E @default.
• Q38447818 P2860 Q38447818-6B0BFE74-44C7-4B05-9B57-1BC149ADE712 @default.
• Q38447818 P2860 Q38447818-7C97C509-B8D6-4690-AABF-926AE92382C2 @default.
• Q38447818 P2860 Q38447818-84F0553D-B1CF-4BCD-BFEC-91E690CE1F46 @default.
• Q38447818 P2860 Q38447818-8A0335E7-D652-4B26-98C8-F8EB70E9AFE9 @default.
• Q38447818 P2860 Q38447818-8E0BD8B4-6162-40B2-B761-F24DAEB2516B @default.
• Q38447818 P2860 Q38447818-90D9D72A-EE3D-4EBA-A5B2-EBFCDF72C2D3 @default.
• Q38447818 P2860 Q38447818-920C8C58-EF01-4EAD-9BC7-E7738E80143B @default.
• Q38447818 P2860 Q38447818-93C9F8D7-C9D0-4AA4-B59F-906DADF4F783 @default.
• Q38447818 P2860 Q38447818-B9C07EBC-59BF-45E0-9297-567877DDB26E @default.
• Q38447818 P2860 Q38447818-CE9B1B43-A0ED-47E5-8E16-4BA8D71AD5B4 @default.
• Q38447818 P2860 Q38447818-D7823E0E-09AC-4F07-8846-0D5E3E29A2C0 @default.
• Q38447818 P2860 Q38447818-E74CA176-8A6B-45E3-8189-0FD72B30FDDF @default.
• Q38447818 P2860 Q38447818-E8CF139A-CA25-4D86-A792-AD19738D0ADE @default.
• Q38447818 P2860 Q38447818-EC91A2BE-3924-470C-B4BA-1A54673DA331 @default.

• next